{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:24:34Z","timestamp":1784089474138,"version":"3.55.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["211086"],"award-info":[{"award-number":["211086"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["358395"],"award-info":[{"award-number":["358395"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aims to re-analyse the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) trial using the win ratio approach to better understand the relative contributions of individual outcomes in a composite endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We applied an unmatched win ratio analysis to the 11 140 participants of the ADVANCE trial, comparing intervention and control groups for blood pressure and glucose control. Outcomes were prioritized hierarchically by severity: cardiovascular death, non-fatal stroke, non-fatal myocardial infarction, nephropathy, and retinopathy. The ADVANCE trial is registered with ClinicalTrials.gov, number NCT00145925. For blood pressure lowering, the perindopril-indapamide group had a win ratio of 1.11 [95% confidence interval (CI) 1.01\u20131.22, P = 0.028] compared to placebo and a net benefit of 1.5% (95% CI 0.2%\u20132.8%) for a number needed to treat (NNT) of 68 patients. For intensive glucose control, the win ratio was 1.10 (95% CI 1.01\u20131.20, P = 0.027) compared to standard glucose control with a net benefit of 1.6% (95% CI 0.2%\u20133.0%) for a NNT of 63 patients. When both interventions were combined, the win ratio increased to 1.19 (95% CI 1.04\u20131.35, P = 0.010) and the NNT decreased to 41 patients. Cardiovascular death and nephropathy were the main contributors to the observed benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The win ratio approach confirms the robustness of the original ADVANCE findings while providing a more detailed understanding of the relative importance of individual outcomes. This method enhances the interpretation and communication of composite endpoint analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvag026","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:58:02Z","timestamp":1777521482000},"page":"258-268","source":"Crossref","is-referenced-by-count":0,"title":["Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: win ratio analysis of ADVANCE trial"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5226-4321","authenticated-orcid":false,"given":"Severine","family":"Bompoint","sequence":"first","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales , Level 8, 55 Botany Road, Randwick, Sydney, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4975-9793","authenticated-orcid":false,"given":"Laurent","family":"Billot","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales , Level 8, 55 Botany Road, Randwick, Sydney, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-4092","authenticated-orcid":false,"given":"Anushka","family":"Patel","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales , Level 8, 55 Botany Road, Randwick, Sydney, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-5296","authenticated-orcid":false,"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales , Level 8, 55 Botany Road, Randwick, Sydney, NSW 2031 ,","place":["Australia"]},{"name":"The George Institute for Global Health, School of Public Health, Imperial College London , London W12 7RZ ,","place":["UK"]},{"name":"Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford , Oxford OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-2869","authenticated-orcid":false,"given":"Katie","family":"Harris","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales , Level 8, 55 Botany Road, Randwick, Sydney, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2907-6714","authenticated-orcid":false,"given":"Stephen","family":"Harrap","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Physiology, Royal Melbourne Hospital, University of Melbourne , Parkville, Victoria 3010 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-3176","authenticated-orcid":false,"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[{"name":"University of Milan-Bicocca , School of Medicine, 20126 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-997X","authenticated-orcid":false,"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, Imperial College London , London W12 7RH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-0580","authenticated-orcid":false,"given":"John","family":"Chalmers","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales , Level 8, 55 Botany Road, Randwick, Sydney, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2026071411423253000_pvag026-B1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"2026071411423253000_pvag026-B2","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"ADVANCE Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"key":"2026071411423253000_pvag026-B3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jacc.2023.06.047","article-title":"Generalized pairwise comparisons to assess treatment effects: JACC Review Topic of the Week","volume":"82","author":"Verbeeck","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026071411423253000_pvag026-B4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"2026071411423253000_pvag026-B5","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/sim.3923","article-title":"Generalized pairwise comparisons of prioritized outcomes in the two-sample problem","volume":"29","author":"Buyse","year":"2010","journal-title":"Stat Med"},{"key":"2026071411423253000_pvag026-B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"2026071411423253000_pvag026-B7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.124.072364","article-title":"Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial","volume":"151","author":"Jaber","year":"2025","journal-title":"Circulation"},{"key":"2026071411423253000_pvag026-B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pst.2251","article-title":"Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes","volume":"22","author":"Dong","year":"2023","journal-title":"Pharm Stat"},{"key":"2026071411423253000_pvag026-B9","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1002\/sim.8967","article-title":"Win odds: an adaptation of the win ratio to include ties","volume":"40","author":"Brunner","year":"2021","journal-title":"Stat Med"},{"key":"2026071411423253000_pvag026-B10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/pst.2293","article-title":"The stratified win statistics (win ratio, win odds, and net benefit)","volume":"22","author":"Dong","year":"2023","journal-title":"Pharm Stat"},{"key":"2026071411423253000_pvag026-B11","unstructured":"Team RC\n          . R: A Language and Environment for Statistical Computing. [R Foundation for Statistical Computing]. 2024."},{"key":"2026071411423253000_pvag026-B12","unstructured":"Cuy \u00a0YHB\n          . WINS: The R WINS Package. [R package]. version 1.4.2. 2024."},{"key":"2026071411423253000_pvag026-B13","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026071411423253000_pvag026-B14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and hypertension: a position statement by the American diabetes association","volume":"40","author":"de Boer","year":"2017","journal-title":"Diabetes Care"},{"key":"2026071411423253000_pvag026-B15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N Engl J Med"},{"key":"2026071411423253000_pvag026-B16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2147\/CIA.S423122","article-title":"Management of glucose-lowering therapy in older adults with type 2 diabetes: challenges and opportunities","volume":"18","author":"Doucet","year":"2023","journal-title":"Clin Interv Aging"},{"key":"2026071411423253000_pvag026-B17","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"2026071411423253000_pvag026-B18","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300286","article-title":"Dapagliflozin in myocardial infarction without diabetes or heart failure","volume":"3","author":"James","year":"2024","journal-title":"NEJM Evid"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag026\/68190141\/pvag026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/258\/68190141\/pvag026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/258\/68190141\/pvag026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:42:39Z","timestamp":1784043759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/12\/4\/258\/8665226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,29]]},"published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag026","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,29]]}}}